SER 8-K 2026-08-26

Serina Therapeutics, Inc. (SER) 8-K dated 2026-08-26 — accession 0001708599-26-000051. This URL is the filing, not the SER hub.

Serina Therapeutics, Inc. (SER) is a biotechnology company listed on AMEX.

Serina Therapeutics, Inc. filed a 8-K on 2026-08-26. Accession 0001708599-26-000051.

Cached items: 1.01, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SER revenue for 2026-06-30 was $0. Net income was -$13.3M. SER currently screens at market cap $29.7M.

Not investment advice. The SER SEC hub lists recent forms. The stock page is the research view.